Literature DB >> 17454675

Impairment of myocardial angiogenic response in the absence of osteopontin.

Xue Zhao1, Jennifer N Johnson, Krishna Singh, Mahipal Singh.   

Abstract

OBJECTIVE: Osteopontin (OPN), increased in the heart following myocardial infarction (MI), plays an important role in post-MI remodeling. Angiogenesis, an important feature of tissue repair, begins in the infarcted myocardium within 3 days post-MI. Here, the authors studied the role of OPN in myocardial angiogenesis using wild-type (WT) and OPN knockout (KO) mice.
RESULTS: Measurement of angiogenic response using Griffonia simplicifolia lectin-1 (GSL-1) staining indicated reduced capillary density in the infarcted region of the OPN KO hearts as compared to WT hearts 7 and 14 days post-MI. Arteriolar density was lower in OPN KO hearts 14 days post-MI. The number of CD31 positive cells was also lower in the infarcted region of the OPN KO hearts as compared to WT hearts 14 days post-MI. In contrast, capillary and arteriolar densities in the noninfarcted regions of OPN KO and WT hearts were not significantly different. In vivo myocardial angiogenesis measured using Matrigel implantation in the left ventricular myocardium indicated significant decrease in the percentage of vessel-like areas in the OPN KO vs. WT hearts. Furthermore, in vitro Matrigel tube formation assay demonstrated a significant decrease in total tube length in cardiac microvascular endothelial cells (CMECs) isolated from OPN KO hearts as compared to CMECs from WT hearts. Treatment of OPN KO CMECs with purified OPN protein significantly increased total tube length, while bovine serum albumin had no effect.
CONCLUSION: Lack of OPN impairs myocardial angiogenic response, leading to adverse remodeling post-MI.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17454675     DOI: 10.1080/10739680601139369

Source DB:  PubMed          Journal:  Microcirculation        ISSN: 1073-9688            Impact factor:   2.628


  10 in total

Review 1.  Extracellular Matrix in Ischemic Heart Disease, Part 4/4: JACC Focus Seminar.

Authors:  Nikolaos G Frangogiannis; Jason C Kovacic
Journal:  J Am Coll Cardiol       Date:  2020-05-05       Impact factor: 24.094

Review 2.  Role of osteopontin in heart failure associated with aging.

Authors:  Mahipal Singh; Cerrone R Foster; Suman Dalal; Krishna Singh
Journal:  Heart Fail Rev       Date:  2010-09       Impact factor: 4.214

3.  Progesterone and placentation increase secreted phosphoprotein one (SPP1 or osteopontin) in uterine glands and stroma for histotrophic and hematotrophic support of ovine pregnancy.

Authors:  Kathrin A Dunlap; David W Erikson; Robert C Burghardt; Frank J White; Kristey M Reed; Jennifer L Farmer; Thomas E Spencer; Ronald R Magness; Fuller W Bazer; Kayla J Bayless; Greg A Johnson
Journal:  Biol Reprod       Date:  2008-07-30       Impact factor: 4.285

Review 4.  Osteopontin: role in extracellular matrix deposition and myocardial remodeling post-MI.

Authors:  Mahipal Singh; Cerrone R Foster; Suman Dalal; Krishna Singh
Journal:  J Mol Cell Cardiol       Date:  2009-06-30       Impact factor: 5.000

5.  Stage-dependent detection of CD14+ and CD16+ cells in the human heart after myocardial infarction.

Authors:  Frauke S Czepluch; Magdalena Schlegel; Felix Bremmer; Carl L Behnes; Gerd Hasenfuss; Katrin Schäfer
Journal:  Virchows Arch       Date:  2013-07-20       Impact factor: 4.064

6.  Physical inactivity increases endostatin and osteopontin in patients with coronary artery disease.

Authors:  Michael Sponder; Monika Fritzer-Szekeres; Rodrig Marculescu; Brigitte Litschauer; Jeanette Strametz-Juranek
Journal:  Heart Vessels       Date:  2015-12-11       Impact factor: 2.037

7.  Normal versus Pathological Cardiac Fibroblast-Derived Extracellular Matrix Differentially Modulates Cardiosphere-Derived Cell Paracrine Properties and Commitment.

Authors:  Francesca Pagano; Francesco Angelini; Clotilde Castaldo; Vittorio Picchio; Elisa Messina; Sebastiano Sciarretta; Ciro Maiello; Giuseppe Biondi-Zoccai; Giacomo Frati; Franca di Meglio; Daria Nurzynska; Isotta Chimenti
Journal:  Stem Cells Int       Date:  2017-06-27       Impact factor: 5.443

8.  Osteopontin Deficiency Suppresses Intestinal Tumor Development in Apc-Deficient Min Mice.

Authors:  Rikako Ishigamori; Masami Komiya; Shinji Takasu; Michihiro Mutoh; Toshio Imai; Mami Takahashi
Journal:  Int J Mol Sci       Date:  2017-05-14       Impact factor: 5.923

9.  Osteopontin - a biomarker of disease, but also of stage stratification of the functional myocardial contractile deficit by chronic ischaemic heart disease.

Authors:  Bogdan-Ioan Coculescu; Gheorghe Manole; Gabi Valeriu Dincă; Elena Claudia Coculescu; Cristina Berteanu; Cristina Mariana Stocheci
Journal:  J Enzyme Inhib Med Chem       Date:  2019-12       Impact factor: 5.051

Review 10.  Clinical and Molecular Implications of Osteopontin in Heart Failure.

Authors:  Argen Mamazhakypov; Meerim Sartmyrzaeva; Akpay Sh Sarybaev; Ralph Schermuly; Akylbek Sydykov
Journal:  Curr Issues Mol Biol       Date:  2022-08-11       Impact factor: 2.976

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.